Panagora Asset Management Inc Vaccinex, Inc. Transaction History

Panagora Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$2.11 - $2.81 $934 - $1,244	-443 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$2.01 - $3.0 $46 - $69	-23 Reduced 4.94%	443 $1,000
Q4 2020 Feb 10, 2021	BUY	$1.66 - $2.35 $773 - $1,095	466 New	466 $1,000
Q4 2019 Feb 12, 2020	SELL	$4.56 - $7.45 $775 - $1,266	-170 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$4.02 - $7.93 $10,218 - $20,158	-2,542 Reduced 93.73%	170 $1,000

Q2 2019 Aug 09, 2019	SELL	$4.89 - $8.11 $1,085 - $1,800	-222 Reduced 7.57%	2,712 $15,000
Q1 2019 May 15, 2019	BUY	$3.67 - $5.5 $5,024 - $7,529	1,369 Added 87.48%	2,934 $15,000
Q4 2018 Feb 14, 2019	BUY	$3.64 - $7.12 $5,696 - $11,142	1,565 New	1,565 $6,000

426K

Ticker VCNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,664,100
Market Cap $287M
Description
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.